A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease

NCT02562768 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: LY3154207
DRUG: Placebo

Sponsor

Eli Lilly and Company